Alzheimer’s disease (AD) is an invariably fatal neurodegenerative disorder and the leading cause of senile dementia worldwide. There is no effective treatment and limited functionality for early unequivocal diagnosis.  Now, a study led by researchers at Cedars-Sinai provides the scientific basis for using noninvasive eye imaging to detect the pathological hallmarks of Alzheimer’s. The team state their experimental technology scans the